{
  "trial_id": "NCT01286077",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Adult Multiple Myeloma patients in partial response or better after high dose chemotherapy and autologous stem cell transplantation",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patient fulfills defined laboratory requirements within 14 days before enrolment",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "If female, is either postmenopausal for more than 24 consecutive months or surgically sterilized or willing to use an acceptable method of birth control for defined period",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "If male, agree to use an acceptable barrier method of contraception and to not donate sperm up to 3 months following treatment",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patient received another antimyeloma or experimental therapy following autologous stem cell transplantation",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Patient has a peripheral neuropathy or neuropathic pain of grade 2 or greater intensity as defined by the NCI common terminology criteria of adverse event (NCI CTCAE) version 3.0",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient is diagnosed with Paget's disease of bone and has a sister with the same condition.",
  "_meta": {
    "topic_id": "74",
    "trial_id": "NCT01286077",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}